Frontlight ResearchEarly access
What researchers published on Triple-negative breast cancer
19,695 papers, newest first.
Showing 60 of 19,695
RGDfC-functionalized gold nanoclusters versus the clinical radiosensitizer sodium glycididazole in triple-negative breast cancer radiotherapy.PloS one
Phase-Space Distance Between Stationary States Modulates Phenotypic Plasticity in Breast Cancer.Bulletin of mathematical biology
Tumor-targeted transferrin nanoassemblies delivering olaparib and curcumin for combating BCRP-mediated resistance in triple-negative breast cancer.Biomaterials science
Case reportPembrolizumab-Associated Secondary Adrenal Insufficiency Due to Isolated Adrenocorticotropic Hormone (ACTH) Deficiency Presenting as Recurrent Multisystem Decompensation in Triple-Negative Breast Cancer.Cureus
Tertiary lymphoid structures and the systemic immune-inflammation index define distinct pathologic response phenotypes in triple-negative breast cancer receiving neoadjuvant chemoimmunotherapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
MRI Radiomics-Based Nomogram Integrating Skeletal Muscle Assessment for Predicting Pathologic Complete Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.Diagnostics (Basel, Switzerland)
β-galactosidase-activatable photosensitization for selective, light-amplified pyroptosis therapy of triple-negative breast Cancer cells.Bioorganic chemistry
In Vitro Models of Triple-Negative Breast Cancer of Sub-Saharan African Ancestry Suggest BLM-Centred DNA Damage Repair Dependency and Pevonedistat Sensitivity.International journal of molecular sciences
ReviewThe Role of Hypoxia-Inducible Factors (HIFs) in Triple-Negative Breast Cancer Radiation Resistance.International journal of molecular sciences
Leptin-Driven Distinct Transcriptional Reprogramming in Triple-Negative Breast Cancer: Implications for Racial Disparities.International journal of molecular sciences
Meta-analysisSurvival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis.Breast cancer research and treatment
Promoter hypomethylation associated with elevated TRIM33 expression in triple-negative breast cancer patients.Frontiers in oncology
Early Change in the Pan-Immune-Inflammation Value During Neoadjuvant Chemotherapy Is Associated with Pathological Complete Response in HER2-Positive and Triple-Negative Breast Cancer: A Single-Centre Study with Temporal Validation.Journal of clinical medicine
ReviewRecent Advances in Mitochondria-Targeted Nanoparticle Photodynamic Therapy for Triple-Negative Breast Cancer.International journal of molecular sciences
RETRACTED: Kim et al. Autocrine Motility Factor and Its Peptide Derivative Inhibit Triple-Negative Breast Cancer by Regulating Wound Repair, Survival, and Drug Efflux. Int. J. Mol. Sci. 2024, 25, 11714.International journal of molecular sciences
Updated results from ASCENT-J02, a study of sacituzumab govitecan in Japanese participants with metastatic triple-negative breast cancer.International journal of clinical oncology
ReviewSQSTM1/p62 and Mitochondrial Stress in Triple-Negative Breast Cancer: A Critical Pathology Perspective.Cancers
Targeting AP1S1 modulates the unfolded protein response and cell cycle and sensitizes triple-negative breast cancer to erlotinib.Tissue & cell
Matrix-Associated Gene Expression and Annotated Tumor-Stroma Composition of Transcriptomically Defined Cold Regions in Triple-Negative Breast Cancer.Cancers
Oral 25-Hydroxycholesterol Suppresses 4T1 Tumour Growth in an Immune-Context-Associated Manner.International journal of molecular sciences
Neoadjuvant Versus Adjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer: A National Cancer Database Study.Cancers
ReviewCirculating Non-Coding RNAs as Liquid Biopsy Biomarkers for Early Detection of Triple-Negative Breast Cancer: From Diagnostic Performance to Clinical Translation.Diagnostics (Basel, Switzerland)
Cell-Cell Communication Network Analysis of Tertiary Lymphoid Structures in Triple-Negative Breast Cancer.Current cancer drug targets
CD39+CD71+ erythroid cells exhibit enhanced purine metabolism and T cell-suppressive function in triple-negative breast cancer and other immunoregulatory settings.Journal of immunology (Baltimore, Md. : 1950)
Dual-Targeted Nanoparticle Chimeras Induce Bioenergetic Crisis by Coupling Lipid Droplet Degradation with Nicotinamide Adenine Dinucleotide Reduction in Triple-Negative Breast Cancer.Acta biomaterialia
Targeting the SND1-MTDH/FANCD2 axis impairs DNA repair and sensitizes triple-negative breast cancer to PARP inhibitor.Pharmacological research
FOXA1 expression and survival outcomes in triple-negative breast cancer: A retrospective cohort study.PloS one
Beyond resveratrol: Vitis vinifera grape cane extracts selectively induce apoptosis in glioblastoma and triple-negative breast cancer cells via Bcl-2/Bax/Caspase-3 pathway.Fitoterapia
HOXC12 Expression in Triple-negative Breast Cancer: Clinicopathological Correlations and Potential as a Prognostic Biomarker.Current drug targets
ReviewThe HLA-E-NKG2A axis in breast cancer: an emerging NK-cell checkpoint and therapeutic target.Frontiers in immunology
Patient-reported outcomes from ASCENT-03: sacituzumab govitecan vs chemotherapy in advanced triple-negative breast cancer.The oncologist
Correction: Eustace et al. TP53 Mutation-Specific Dysregulation of Store-Operated Calcium Entry and Apoptotic Sensitivity in Triple-Negative Breast Cancer. Cancers 2025, 17, 1614.Cancers
Effectiveness and Toxicity Burden of Pembrolizumab in Combination With Neoadjuvant Chemotherapy for Stage II/III Triple Negative Breast Cancer: A Real-World Analysis From Alberta, Canada.American journal of clinical oncology
Real-world use of pembrolizumab in early-stage triple-negative breast cancer: Data from the French Early Access Program.Breast (Edinburgh, Scotland)
SIMMPYRA1 and SIMMPYRA2 suppress triple-negative breast cancer growth through selective STAT3 inhibition.Cell chemical biology
Relevance of toll-like receptor-4 in the pathogenesis of triple negative breast cancer.Molecular biology reports
CDK4/6-Mediated Growth Arrest Enhances Cell Stiffness and Contractility in RB-Proficient Triple-Negative Breast Cancer Cells in 3D Hydrogels.Tissue engineering. Part A
RBP1-driven retinol metabolism in tumor-associated lymphatic endothelial cells orchestrates triple-negative breast cancer progression and lymphatic metastasis.Experimental hematology & oncology
Treatment-associated remodeling of a mitochondrial translation-related gene set in paired pretreatment and residual triple-negative breast tumors.Neoplasia (New York, N.Y.)
Comprehensive characterization of the cellular and molecular consequences of LCN2 loss in MDA-MB-231 triple-negative breast cancer cells.Frontiers in cell and developmental biology
Claims-defined adrenal insufficiency, hypothyroidism, and type 1 diabetes after immune checkpoint inhibitor initiation in patients with triple-negative breast cancer in Japan.Breast cancer (Tokyo, Japan)
ReviewGlutamine as a context-dependent regulator controlling metabolism and immunity in triple-negative breast cancer.Cell communication and signaling : CCS
Meta-analysisReal-world effectiveness and safety of neoadjuvant pembrolizumab in early-stage triple-negative breast cancer: a systematic review and meta-analysis.BMC cancer
Analyzing per- and polyfluoroalkyl substances (PFAS) in triple-negative breast cancer (TNBC): an integrative transcriptomic and computational study.Cell biology and toxicology
Antibody-drug conjugates therapy for triple-negative breast cancer: a systematic review and meta-analysis.Frontiers in medicine
CD39-associated myeloid-T-cell coordination within an immunoregulatory neighborhood linked to treatment resistance in triple-negative breast cancer.Breast cancer research : BCR
Bifunctional EGFR/CD44-Targeted Diabody-Decorated Doxorubicin-Loaded Solid Lipid Nanoparticles for Targeted Therapy in Triple-Negative Breast Cancer.Advanced pharmaceutical bulletin
Egonol restores tamoxifen sensitivity via the miR-3529-5p-CLOCK axis in triple-negative breast cancer cells.Fitoterapia
Effect of Exosome-loaded hsa-miR-203a-3p on Triple Negative Breast Cancer Cell Viability, Migration, and Gene Targets: In Silico and In Vitro Study.Advanced pharmaceutical bulletin
CD97 Modulates M1-Like Macrophage Activation and Function to Influence the Immune Microenvironment and Tumor Progression in Triple-Negative Breast Cancer.Journal of inflammation research
CircEML1 upregulates BTG2 to suppress the progression of triple-negative breast cancer.Biology direct
Biotin-Functionalized Multi-Stimuli-Responsive Polymeric Prodrug for Receptor-Mediated and Mitochondria-Targeted Codelivery of Camptothecin and Protocatechualdehyde.Biomacromolecules
Targeting CD44v3 rescues Entrectinib response in brain metastasis of triple negative breast cancer overexpressing TrkA.Signal transduction and targeted therapy
Decoding neutrophil spatial heterogeneity and clinical implications in breast cancer.Cancer cell
Geographical access to radiotherapy and surgical treatment selection in older women with HER2-positive and triple-negative breast cancer: A real-world exploratory study.Journal of geriatric oncology
Durable Treatment-Free Remission in BRCA1-Associated Metastatic Triple-Negative Breast Cancer with Brain and Radiologically Diagnosed Hepatic Metastases: A Case Report.Oncology and therapy
ReviewBrain Metastasis of Triple-Negative Breast Cancer: Mechanisms and Emerging Therapeutic Strategies.The breast journal
Subtype conversion and metastatic timing in breast cancer liver metastasis.World journal of surgical oncology
Neutrophils are known by their neighbors in breast cancer.Cancer cell
Hyaluronic acid-engineered NLCs as a macromolecular delivery platform for APOBEC3B siRNA and gemcitabine in triple-negative breast cancer: In vitro to in ovo assay.International journal of biological macromolecules